文献
J-GLOBAL ID:201802283482662168
整理番号:18A0886388
転移性大腸癌患者の第一選択治療としてのS-1とイリノテカン併用ベバシズマブ対mFOLFOX6あるいはCapeOX併用ベバシズマブ(TRICOLORE):無作為化非盲検第III相非劣性試験
S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial
著者 (20件):
YAMADA Y.
(National Cancer Center Hospital, Tokyo)
,
DENDA T.
(Chiba Cancer Center, Chiba)
,
GAMOH M.
(Osaki Citizen Hospital, Miyagi)
,
IWANAGA I.
(Japanese Red Cross Kitami Hospital, Hokkaido)
,
YUKI S.
(Hokkaido Univ. Hospital, Hokkaido)
,
SHIMODAIRA H.
(Tohoku Univ. Hospital, Miyagi)
,
NAKAMURA M.
(Aizawa Hospital, Nagano)
,
YAMAGUCHI T.
(Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo)
,
OHORI H.
(Japanese Red Cross Ishinomaki Hospital, Miyagi)
,
KOBAYASHI K.
(Showa Univ. Northern Yokohama Hospital, Kanagawa)
,
TSUDA M.
(Hyogo Cancer Center, Hyogo)
,
KOBAYASHI Y.
(Kushiro Rosai Hospital, Hokkaido)
,
MIYAMOTO Y.
(Kumamoto Univ., Kumamoto)
,
KOTAKE M.
(Kouseiren Takaoka Hospital, Toyama)
,
SHIMADA K.
(Showa Univ. Koto Toyosu Hospital, Tokyo)
,
SATO A.
(Hirosaki Univ. Graduate School of Medicine, Aomori)
,
MORITA S.
(Kyoto Univ. Graduate School of Medicine, Kyoto)
,
TAKAHASHI S.
(Tohoku Univ. Hospital, Miyagi)
,
KOMATSU Y.
(Hokkaido Univ. Hospital Cancer Center, Hokkaido, JPN)
,
ISHIOKA C.
(Tohoku Univ. Hospital, Miyagi)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
29
号:
3
ページ:
624-631
発行年:
2018年03月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)